orlistat 120 mg (Xenical, authorized generic) — Medical Mutual
Weight Loss, Pediatric
Initial criteria
- Patient is ≥ 12 years of age and < 18 years of age; AND
- Patient currently has a BMI ≥ 95th percentile for age and sex; AND
- Patient has engaged in a trial of behavioral modification and dietary restriction for at least 3 months and has failed to limit weight gain or modify comorbidities; AND
- Patient is currently engaged in behavioral modification and on a reduced calorie diet
Reauthorization criteria
- Patient is ≥ 12 years of age and < 18 years of age; AND
- Patient had an initial BMI ≥ 95th percentile for age and sex; AND
- Patient is currently engaged in behavioral modification and on a reduced calorie diet; AND
- Patient’s current BMI percentile has decreased for age and weight (accounting for growth in height)
Approval duration
3 months initial, 1 year continuation